Helping people understand theranostics and the future of precision cancer care.
Theranostics is transforming how some cancers are diagnosed and treated through the combination of advanced imaging and targeted therapy. Whether you are a patient, caregiver, healthcare professional, researcher or policymaker, Oncothera Advocacy provides trusted information, educational resources and opportunities to connect with the theranostics community.
Oncothera Advocacy is committed to improving awareness, education, access and collaboration in theranostics. Through trusted information, advocacy initiatives and stakeholder engagement, we support patients, clinicians and communities navigating the future of precision cancer care.
Oncothera Advocacy aims to share unbiased information about the theranostics category, research and may mention medical diagnosis or treatment options. This information is provided with the objective of growing the category as a whole by educating health professionals and general public. All content found on this website, including: text, images, audio, video or any other formats are created for informational purposes only. Content is not intended to be a substitute for professional medical advice, diagnosis or treatment and should not be treated as such.
What Is Theranostics?
Theranostics combines diagnostics and radiotherapy to help personalise cancer care. By using advanced imaging to identify specific biological targets and then delivering targeted treatment to those same targets, theranostics represents one of the most significant developments in precision oncology.
While the field continues to evolve, theranostics is already helping improve treatment pathways for some patients with prostate cancer, neuroendocrine tumours and other cancers.
Whether you are new to theranostics or looking to deepen your understanding, our Theranostics Hub provides clear, evidence-based information designed for patients, healthcare professionals and the broader community.
A More Personalised Approach to Cancer Care
Cancer is not one disease, and every patient's journey is different. Advances in precision medicine are creating opportunities to better understand individual cancers and tailor treatment approaches accordingly.
Theranostics supports this shift by helping clinicians visualise disease, assess suitability for targeted therapies and monitor treatment response. As research progresses, theranostics has the potential to play an increasingly important role in improving patient outcomes and expanding treatment options.
A Centre of Excellence Connecting Patients, Policy and Practitioners
PATIENT SUPPORT
Helping Patients and Families Navigate Their Journey
A cancer diagnosis can raise many questions. Our Patient Support section has been developed to provide practical, easy-to-understand information to help patients and caregivers better understand theranostics, treatment pathways and available resources.
Topics include:
-
Understanding your diagnosis
-
What to expect from treatment
-
Questions to ask your healthcare team
-
Patient stories and experiences
-
Additional support resources
CLINICIANS & RESEARCH
Advancing Knowledge Through Collaboration
Theranostics sits at the intersection of oncology, nuclear medicine, imaging, research and innovation. Oncothera Advocacy supports collaboration and knowledge sharing across the healthcare ecosystem.
Access clinical perspectives, research updates, educational resources, conference insights and opportunities to engage with the broader theranostics community.
ADVOCACY IN ACTION
Supporting Awareness, Access and Collaboration
Oncothera Advocacy works to increase awareness of theranostics, improve access to education and resources, and foster collaboration across the healthcare ecosystem.
By bringing together patients, clinicians, researchers, industry and policymakers, we aim to support the continued growth of theranostics and its potential impact on patient care.
LATEST INSIGHTS
Explore the Latest News, Research and Perspectives
Stay informed with expert commentary, educational articles, patient stories, advocacy updates and insights from across the theranostics landscape.
Featured articles:
-
Theranostics: A New Era of Precision Cancer Care
-
Theranostics vs Traditional Cancer Treatments
-
How Theranostics Is Transforming Prostate Cancer Care
JOIN THE COMMUNITY
Stay Connected to the Future of Theranostics
Join our community to receive educational resources, industry updates, event invitations and the latest developments in theranostics delivered directly to your inbox.
Whether you are a patient, healthcare professional, researcher, advocate or supporter, we invite you to be part of the conversation.
SUPPORT OUR WORK
Help Grow Awareness, Education and Advocacy
As an independent advocacy organisation, Oncothera relies on the support of partners, sponsors and donors to continue delivering trusted education, resources and initiatives that benefit the theranostics community.
Your support helps us advance awareness, foster collaboration and contribute to a more informed future for precision cancer care.
WHY THERANOSTICS MATTERS
Discover the Future of Theranostics
Healthcare is moving towards a future where treatment is increasingly tailored to the individual. Theranostics is helping drive this transformation by combining advanced diagnostic imaging with targeted therapies to support more personalised approaches to care.
Already benefiting selected patients across several cancer types, theranostics is enabling clinicians to better understand disease, guide treatment decisions and monitor response over time. As innovation continues, theranostics is expected to play an increasingly important role in precision medicine, helping improve outcomes and expand treatment possibilities for future generations.
The Patient Journey
Every patient's experience is unique, but theranostics can play an important role at several stages of the care journey. By combining advanced imaging and targeted therapy, theranostics helps clinicians better understand disease, guide treatment decisions and monitor response over time.
-
Diagnosis
The journey often begins with a diagnosis and an assessment of the type, stage and characteristics of a patient's disease.
-
Imaging & Assessment
Advanced molecular imaging may be used to identify specific biological targets and determine whether a patient may be suitable for a theranostic approach.
-
Treatment Planning
Healthcare teams use diagnostic information, clinical evidence and individual patient factors to develop a personalised treatment strategy.
-
Targeted Therapy
For selected patients, targeted radiotherapy can be used to deliver treatment directly to cancer cells while helping to minimise impact on surrounding healthy tissue.
-
Monitoring & Follow-Up
Ongoing imaging and clinical assessments help clinicians evaluate treatment response, monitor disease progression and support future care decisions.
Theranostics is helping create a more personalised approach to healthcare, providing patients and clinicians with valuable information that can support informed decision-making throughout the treatment journey.
PARTNERSHIPS & COLLABORATION
Collaboration Drives Progress
Theranostics sits at the intersection of medicine, research, technology, advocacy and patient care. Advancing the field requires collaboration between clinicians, researchers, healthcare organisations, industry, policymakers and patients.
Oncothera Advocacy works to bring these stakeholders together through education, dialogue and shared initiatives that support the continued growth of theranostics.
By pooling expertise and resources, these collaborations aim to accelerate the development of innovative theranostic technologies, enhance patient care, and ultimately improve outcomes for individuals with various diseases.
We are committed to making a meaningful impact in the healthcare landscape.
Continue Exploring